Overview

  • Product nameAnti-POTED antibody
  • Description
    Rabbit polyclonal to POTED
  • Tested applicationsSuitable for: IHC-P, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    KLH conjugated synthetic peptide selected from the C terminal region of human POTE.

  • Positive control
    • Human prostate carcinoma tissue

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: 0.09% Sodium Azide
    Constituents: PBS
  • Concentration information loading...
  • PurityProtein A purified
  • Purification notesThis antibody is purified through a protein A column, followed by peptide affinity purification.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab76698 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/10 - 1/50.
ELISA 1/1000.

Target

  • RelevancePOTED belongs to the POTE family and contains 6 ANK repeats. It is expressed in prostate, ovary, testis, placenta and prostate cancer cell lines. Localizes to basal and terminal prostate epithelial cells.
  • Cellular localizationCell membrane; Peripheral membrane protein.
  • Database links
  • Alternative names
    • A26B3 antibody
    • ANKRD21 antibody
    • ANKRD26 like family B member 3 antibody
    • Ankyrin repeat domain containing protein 21 antibody
    • POTE21 antibody
    • Prostate, ovary, testis expressed protein antibody
    • Protein POTE antibody
    see all

Anti-POTED antibody images

  • Formalin fixed, paraffin embedded human prostate carcinoma tissue was stained with ab76698 at a 1/10 dilution, followed by peroxidase conjugated secondary antibody and DAB staining.

References for Anti-POTED antibody (ab76698)

This product has been referenced in:
  • Redfield SM  et al. The C-terminal common to group 3 POTES (CtG3P): a newly discovered nucleolar marker associated with malignant progression and metastasis. Am J Cancer Res 3:278-89 (2013). IHC-P ; Human . Read more (PubMed: 23841027) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab76698.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"